Adobe Systems Inc. (ADBE US) rose 5.8 percent to $26.06. The world's largest maker of graphic-design software forecast fourth-quarter revenue of at least $1.08 billion, exceeding analysts' estimates of $1.07 billion on average, citing demand from business customers.
Alpha Natural Resources Inc. (ANR US) fell 9.8 percent to $24.28. The Abingdon, Virginia-based coal company cut its 2011 shipment forecast to 103 to 110 million tons from a range of 104 to 112 million tons. The mining company said it reduced shipments to Asia and had lower production from some of its mines.
Arch Coal Inc. (ACI US) lost 5.7 percent to $16.99, Patriot Coal Corp. (PCX US) retreated 6.4 percent to $10.68, Teck Resources Ltd. (TCK US) slipped 2.8 percent to $35.29 and Peabody Energy Corp. (BTU US) declined 2.6 percent to $41.79.
Analogic Corp. (ALOG US) rallied 9.2 percent to $48.86. The medical and airport-security device maker reported fourth- quarter earnings of 83 cents a share, beating the 62 cent average estimate of two analysts.
Molycorp Inc. (MCP US) rose 4.4 percent to $43.28. The owner of the largest rare-earth deposit outside China had its “buy” rating reiterated by Anthony Young, an analyst at Dahlman Rose & Co., after the shares plunged 22 percent yesterday. Molycorp Chief Executive Officer Mark Smith told CNBC that he expects no change in supply and demand. Morgan Stanley forecast rare earth prices will stabilize in the fourth quarter.
Oracle Corp. (ORCL US) gained 7 percent to $30.33. The Redwood City, California-based supplier reported a first-quarter profit of 48 cents, topping analysts' estimates by 1 cent, as companies increased spending on database software and applications that help run their businesses.
Red Hat Inc. (RHT US), an Oracle competitor, rose 3 percent to $41.28.
Orexigen Therapeutics Inc. (OREX US) surged 62 percent to $2.38. The drugmaker, which is one of three companies with rival obesity treatments competing for approval, is renewing development of the experiment obesity drug Contrave after reaching an agreement with U.S. regulators to further study heart risks.
Vivus Inc. (VVUS US), which has been vying to introduce the first new obesity medicine in the U.S., rose 2.2 percent to $8.81.
PharMerica Corp. (PMC US) rose 1.6 percent to $14.62. The provider of pharmacy services based said its board unanimously voted to reject a hostile bid by Omnicare Inc. to acquire the Louisville, Kentucky-based company for $15 a share.
Realty Income Corp. (O US) declined 2 percent to $33.76. The real estate investment trust that acquires retail locations started a public offering of 6 million shares. Proceeds will be used to pay debt.
Walter Energy Inc. (WLT US) fell 13 percent to $65.15. The coal producer that bought Western Coal Corp. in April lowered its second-half sales forecast because of delays at mines in British Columbia and Alabama.
For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment